Characterization of liver, adipose, and fecal microbiome in obese patients with MASLD: links with disease severity and metabolic dysfunction parameters
Microbiome · 2025
DOI: 10.1186/s40168-024-02004-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbiome, 2025. Verfasst von Katherine J P Schwenger und 9 weiteren Autor:innen. Beteiligte Einrichtung: Toronto General Hospital, University Health Network, Toronto, Canada. Hauptthemen laut MEDLINE: Obesity, Feces, Liver, Adipose Tissue. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Canadian Institutes of Health Research, American College of Gastroenterology Bridge Award, Canadian Liver Foundation.
Abstract (Originalsprache)
Background
Metabolic dysfunction-associated steatotic liver disease (MASLD) encompasses a range of histological findings from the generally benign simple steatosis to steatohepatitis (MASH) which can progress to fibrosis and cirrhosis. Several factors, including the microbiome, may contribute to disease progression.
Results
Here, we demonstrate links between the presence and abundance of specific bacteria in the adipose and liver tissues, inflammatory genes, immune cell responses, and disease severity. Overall, in MASLD patients, we observed a generalized obesity-induced translocation of gut bacteria to hepatic and adipose tissues. We identified microbial patterns unique to more severely diseased tissues. Specifically, Enterococcus , Granulicatella , and Morganellaceae abundance is positively correlated with immune cell counts and inflammatory gene expression levels, and both genera are significantly enriched in MASH patients. Brevibacterium is enriched in adipose tissues of patients with liver fibrosis.
Conclusion
Together, these results provide further insight into the microbial factors that may be driving disease severity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Toronto General Hospital, University Health Network, Toronto, Canada.
- Centre for the Analysis of Genome Evolution & Function, University of Toronto, Toronto, Canada.
- Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Canada.
- Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada.
- Department of Nutritional Sciences, University of Toronto, Toronto, Canada.
- Division of General Surgery, University of Toronto, Toronto, Canada.
Förderung
- Canadian Institutes of Health Research
- American College of Gastroenterology Bridge Award
- Canadian Liver Foundation
Zitieren
APA
Schwenger, K. J. P., Copeland, J. K., Ghorbani, Y., Chen, L., Comelli, E. M., Guttman, D. S., Fischer, S. E., Jackson, T. D., Okrainec, A., & Allard, J. P. (2025). Characterization of liver, adipose, and fecal microbiome in obese patients with MASLD: links with disease severity and metabolic dysfunction parameters. Microbiome. https://doi.org/10.1186/s40168-024-02004-7
Vancouver
Schwenger KJP, Copeland JK, Ghorbani Y, Chen L, Comelli EM, Guttman DS, et al. Characterization of liver, adipose, and fecal microbiome in obese patients with MASLD: links with disease severity and metabolic dysfunction parameters. Microbiome. 2025. doi:10.1186/s40168-024-02004-7
BibTeX
@article{Schwenger2025,
author = {Schwenger, Katherine J P and Copeland, Julia K and Ghorbani, Yasaman and Chen, Lina and Comelli, Elena M and Guttman, David S and Fischer, Sandra E and Jackson, Timothy D and Okrainec, Allan and Allard, Johane P},
title = {Characterization of liver, adipose, and fecal microbiome in obese patients with MASLD: links with disease severity and metabolic dysfunction parameters},
journal = {Microbiome},
year = {2025},
doi = {10.1186/s40168-024-02004-7}
}
EUVIMED